Clinical Trials
IQVIA selected to accelerate clinical development of VYVGART by argenx SE
IQVIA announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new indications for VYVGART™ (efgartigimod alfa fcab), an FDA-approved neonatal Fc receptor blocker for the treatment of generalized myasthenia gravis...
Press Releases
Element Partners with Interpretation Expert Genoox to Validate the AVITI System for the RUGD Application
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, announced a partnership with Genoox, a community-driven genomic data platform, to demonstrate the clinical potential of the AVITI™ system for rare and undiagnosed disease research, using whole-genome...
Drug Research
Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories...
Press Releases
Eagle Genomics Continues Strategic Global Expansion with Three New Appointments in UK and India
Eagle Genomics, the Deep Tech platform business pioneering the application of network science to biology across the Food and Nutrition, Beauty and Personal Care, AgBio and Biopharma industries, announced three new senior appointments in the UK and India as...
Press Releases
Trialbee to Power Patient Recruitment for ERGOMED’s New Rare Disease Innovation Center
Trialbee, the leader in technology-based patient matching and enrollment, has partnered with global clinical research organization ERGOMED plc to be the patient recruitment platform for their newly launched Rare Disease Innovation Center, partnering with their own novel Site Advantage™...
Press Releases
Bayer delivers on medical innovation fueling transformation of pharma business
At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients.
“We are taking bold...
Press Releases
ERGOMED announces launch of its Rare Disease Innovation Center
ERGOMED plc a leading Clinical Research Organization focused on rare disease drug development today announced the establishment of its Rare Disease Innovation Center.
Rare diseases impact around 300 million people worldwide. For each disease, clinical trial sponsors face major challenges...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read